04 | MD Anderson Cancer Center

April 30, 2021

A Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center found that BK virus (BKV)-specific T cells...

April 14, 2021

The University of Texas MD Anderson Cancer Center and Boehringer Ingelheim today announced the extension and expansion of their joint...

April 12, 2021

Abstract #LB008

A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug...

April 10, 2021

ABSTRACT #2417 Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most...

April 08, 2021

The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences today announced a strategic research collaboration to...

Help #EndCancer